Blue Water Life Science Advisors, LP Guardant Health, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $101 Million
- Q1 2025
A detailed history of Blue Water Life Science Advisors, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 694,047 shares of GH stock, worth $37.6 Million. This represents 29.3% of its overall portfolio holdings.
Number of Shares
694,047
Previous 694,047
-0.0%
Holding current value
$37.6 Million
Previous $21.2 Million
39.44%
% of portfolio
29.3%
Previous 19.29%
Shares
14 transactions
Others Institutions Holding GH
# of Institutions
403Shares Held
123MCall Options Held
1.43MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.1MShares$655 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$609 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$295 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$279 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$261 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.54B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...